Evidence map›Paper›PMID 25044348›Full record

ArticleAngewandte Chemie (International ed. in English)2014

Analysis of diazofluorene DNA binding and damaging activity: DNA cleavage by a synthetic monomeric diazofluorene.

Christina M Woo, Nihar Ranjan, Dev P Arya, Seth B Herzon

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Synthesis and Biological Evaluation of (2Journal of the American Chemical Society · 2021
    Article
  4. Review
  5. Review
  6. Article
  7. Structural basis for DNA cleavage by the potent antiproliferative agent (-)-lomaiviticin A.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Christina M WooDepartment of Chemistry, Yale University, 225 Prospect Street, New Haven, CT 06520-8107 (USA) http://www.chem.yale.edu/herzongroup.
Nihar Ranjan
Dev P Arya
Seth B Herzon

Funding

Synthetic, Chemical Biological, and Preclinical Studies of Antitumor Natural Products and Their DerivativesR01GM090000 · NIGMS · YALE UNIVERSITY · PI HERZON, SETH B. · 2011 to 2018
$2.4M
A novel assay for RNA targeted drugsR41GM097917 · NIGMS · NUBAD, LLC · PI ARYA, DEV PRIYA · 2011 to 2011
$286k
NIGMS NIH HHS 1R41GM097917NIGMS NIH HHS 5R01GM090000NIGMS NIH HHS R01 GM090000NIGMS NIH HHS R41 GM097917
6 · The paper itself

Abstract

The lomaiviticins and kinamycins are complex DNA damaging natural products that contain a diazofluorene functional group. Herein, we elucidate the influence of skeleton structure, ring and chain isomerization, D-ring oxidation state, and naphthoquinone substitution on DNA binding and damaging activity. We show that the electrophilicity of the diazofluorene appears to be a significant determinant of DNA damaging activity. These studies identify the monomeric diazofluorene 11 as a potent DNA cleavage agent in tissue culture. The simpler structure of 11 relative to the natural products establishes it as a useful lead for translational studies.

Indexed as

DNA DamageAnimalsBinding SitesCattleDiazonium CompoundsDNADNA CleavageDose-Response Relationship, DrugFluorenesMolecular StructureStructure-Activity Relationshipcalf thymus DNADiazonium CompoundsDNAFluorenescancerDNA cleavageDNA damagenatural products

Identifiers

PMID25044348
PMCPMC4206835

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.